| Role |
Name |
Disclosure |
Details |
| Author | Robert A Egan, MD, Director of Neuro-Ophthalmology, St Helena Hospital | Nothing to disclose | Details | | Coauthor | Nicholas Y Lorenzo, MD, Chief Editor, eMedicine Neurology; Consulting Staff, Neurology Specialists and Consultants | Nothing to disclose | Details | | Medical Editor | Eric R Eggenberger, DO, MS, FAAN, Professor, Vice-Chairman, Department of Neurology and Ophthalmology, Colleges of Osteopathic Medicine and Human Medicine, Michigan State University; Director of Michigan State University Ocular Motility Laboratory; Director of National Multiple Sclerosis Society Clinic, Michigan State University | Nothing to disclose | Details | | Pharmacy Editor | Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine | Nothing to disclose | Details | | Managing Editor | Howard S Kirshner, MD, Professor of Neurology, Psychiatry and Hearing and Speech Sciences, Vice Chairman, Department of Neurology, Vanderbilt University School of Medicine; Director, Vanderbilt Stroke Center; Program Director, Stroke Service, Vanderbilt Stallworth Rehabilitation Hospital; Consulting Staff, Department of Neurology, Nashville Veterans Affairs Medical Center | Boehringer Ingelheim BMS/Sanofi Pfizer Novartis | Details | | CME Editor | Matthew J Baker, MD, Consulting Staff, Collier Neurologic Specialists, Naples Community Hospital | Nothing to disclose | Details | | Chief Editor | Helmi L Lutsep, MD, Associate Professor, Department of Neurology, Oregon Health and Science University; Associate Director, Oregon Stroke Center | Co-Axia Talecris AGA Medical Boehringer Ingelheim Boston Scientific Concentric Medical Northstar Neuroscience ev3 | Details |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Matthew J Baker, CME Editor |
The contributor discloses no conflict of interest. |
|